Search Results - "Fitzgerald, R C"

Refine Results
  1. 1
  2. 2

    Molecular basis of Barrett’s oesophagus and oesophageal adenocarcinoma by Fitzgerald, R C

    Published in Gut (01-12-2006)
    “…The rationale for the use of acid suppression arises from the in vitro and ex vivo data discussed above, which suggest that acid may adversely affect cell…”
    Get full text
    Journal Article
  3. 3

    Early diagnosis of oesophageal cancer by Bird-Lieberman, E L, Fitzgerald, R C

    Published in British journal of cancer (07-07-2009)
    “…Squamous cell carcinoma and adenocarcinoma of the oesophagus are cancers that develop from distinct epithelial sub-types; however, they are both related to…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk by Barber, ME, Save, V, Carneiro, F, Dwerryhouse, S, Lao-Sirieix, P, Hardwick, RH, Caldas, C, Fitzgerald, RC

    Published in The Journal of pathology (01-11-2008)
    “…Hereditary diffuse gastric cancer (HDGC) is caused by germline E-cadherin (CDH1) mutations in 25-40% of tested families. Management options for asymptomatic…”
    Get full text
    Journal Article
  6. 6

    Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer by Barber, M, Murrell, A, Ito, Y, Maia, A.T, Hyland, S, Oliveira, C, Save, V, Carneiro, F, Paterson, AL, Grehan, N, Dwerryhouse, S, Lao-Sirieix, P, Caldas, C, Fitzgerald, RC

    Published in The Journal of pathology (01-11-2008)
    “…Around 25-40% of cases of hereditary diffuse gastric cancer (HDGC) are caused by heterozygous E-cadherin (CDH1) germline mutations. The mechanisms for loss of…”
    Get full text
    Journal Article
  7. 7

    Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic by Lao-Sirieix, P, Boussioutas, A, Kadri, S R, O'Donovan, M, Debiram, I, Das, M, Harihar, L, Fitzgerald, R C

    Published in Gut (01-11-2009)
    “…Barrett's oesophagus predisposes to oesophageal adenocarcinoma but the majority of patients are undiagnosed. A novel non-endoscopic cytological screening…”
    Get more information
    Journal Article
  8. 8

    Pilot study of cytological testing for oesophageal squamous cell dysplasia in a high-risk area in Northern Iran by Roshandel, G, Merat, S, Sotoudeh, M, Khoshnia, M, Poustchi, H, Lao-Sirieix, P, Malhotra, S, O'Donovan, M, Etemadi, A, Nickmanesh, A, Pourshams, A, Norouzi, A, Debiram, I, Semnani, S, Abnet, C C, Dawsey, S M, Fitzgerald, R C, Malekzadeh, R

    Published in British journal of cancer (09-12-2014)
    “…Background: Oesophageal squamous cell carcinoma (ESCC) is a fatal disease with 5-year survival rates of <5% in Northern Iran. Oesophageal squamous dysplasia…”
    Get full text
    Journal Article
  9. 9

    Clinical implications of E-cadherin associated hereditary diffuse gastric cancer by Fitzgerald, R C, Caldas, C

    Published in Gut (01-06-2004)
    “…Approximately 1–3% of gastric cancers arise as a result of inherited gastric cancer predisposition syndromes. These may be of the diffuse or intestinal type…”
    Get full text
    Journal Article
  10. 10

    Barrett’s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation? by Fitzgerald, R C

    Published in Gut (01-03-2005)
    “…Acid, a principal component of gastro-oesophageal refluxate, may contribute to the development and malignant progression of Barrett’s oesophagus. Oesophageal…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma by Goh, X Y, Rees, J R E, Paterson, A L, Chin, S F, Marioni, J C, Save, V, O'Donovan, M, Eijk, P P, Alderson, D, Ylstra, B, Caldas, C, Fitzgerald, R C

    Published in Gut (01-10-2011)
    “…The incidence of oesophageal adenocarcinoma (OAC) has been increasing rapidly with a dismal survival rate of less than 20%. Understanding the genomic…”
    Get more information
    Journal Article
  12. 12

    Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression by Ouatu–Lascar, Rodica, Fitzgerald, Rebecca C., Triadafilopoulos, George

    Published in Gastroenterology (New York, N.Y. 1943) (01-08-1999)
    “…Background & Aims: Maintenance of normal epithelial differentiation and proliferation is an important goal in cancer chemoprevention. Because acid has a…”
    Get full text
    Journal Article
  13. 13

    Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants by Fitzgerald, R C, Onwuegbusi, B A, Bajaj-Elliott, M, Saeed, I T, Burnham, W R, Farthing, M J G

    Published in Gut (01-04-2002)
    “…Background and aims: Approximately 10% of adults experience gastro-oesophageal reflux symptoms with a variable oesophageal response. A total of 60% have no…”
    Get full text
    Journal Article
  14. 14

    Inflammatory gradient in Barrett’s oesophagus: implications for disease complications by Fitzgerald, R C, Abdalla, S, Onwuegbusi, B A, Sirieix, P, Saeed, I T, Burnham, W R, Farthing, M J G

    Published in Gut (01-09-2002)
    “…Introduction: Barrett’s oesophageal epithelium (BE) is clinically important due to the associated inflammatory and malignant complications which are unevenly…”
    Get full text
    Journal Article
  15. 15

    Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model by Fitzgerald, R C, Omary, M B, Triadafilopoulos, G

    Published in The Journal of clinical investigation (01-11-1996)
    “…Barrett's esophagus (BE), or specialized intestinal metaplasia, is a premalignant heterogeneous epithelium associated with reflux and an increased risk for…”
    Get full text
    Journal Article
  16. 16

    Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma by Peters, C. J., Hardwick, R. H., Vowler, S. L., Fitzgerald, R. C.

    Published in British journal of surgery (01-07-2009)
    “…Background: Oesophageal adenocarcinoma is the commonest oesophageal malignancy in the West, but is staged using a system designed for squamous cell carcinoma…”
    Get full text
    Journal Article
  17. 17

    A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma by Chang, C-L, Hong, E, Lao-Sirieix, P, Fitzgerald, R C

    Published in Oncogene (08-05-2008)
    “…Vitamin A deficiency is associated with carcinogenesis, and upregulation of CYP26A1, a major retinoic acid (RA)-catabolizing enzyme, has recently been shown in…”
    Get full text
    Journal Article
  18. 18

    Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett's esophagus by Boerwinkel, D. F., Di Pietro, M., Liu, X., Shariff, M. K., Lao-Sirieix, P., Walker, C. E., Visser, M., O' Donovan, M., Kaye, P., Bergman, J. J. G. H. M., Fitzgerald, R C.

    Published in Diseases of the esophagus (01-07-2014)
    “…Summary In Barrett's esophagus (BE), the normal squamous lining of the esophagus is replaced by specialized columnar epithelium. Endoscopic surveillance with…”
    Get full text
    Journal Article
  19. 19

    Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma by PETERS, C. J., FITZGERALD, R. C.

    Published in Alimentary pharmacology & therapeutics (01-06-2007)
    “…Summary Background Oesophageal adenocarcinoma is an increasingly common cancer with a poor prognosis. It develops in a stepwise progression from Barrett’s…”
    Get full text
    Journal Article
  20. 20

    Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation by Onwuegbusi, B A, Aitchison, A, Chin, S-F, Kranjac, T, Mills, I, Huang, Y, Lao-Sirieix, P, Caldas, C, Fitzgerald, R C

    Published in Gut (01-06-2006)
    “…Background and aims: Transforming growth factor β (TGF-β) is frequently involved in gastrointestinal carcinogenesis although its contribution to oesophageal…”
    Get full text
    Journal Article